Emerging therapeutic potential of anti-psychotic drugs in the management of human glioma: A comprehensive review
Authors:
Open Access
- 11 June 2019
- journal article
- review article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 10 (39) , 3952-3977
Abstract
Emerging therapeutic potential of anti-psychotic drugs in the management of human glioma: A comprehensive reviewKeywords
This publication has 130 references indexed in Scilit:
- Treating brain tumors with PDE4 inhibitorsTrends in Pharmacological Sciences, 2011
- MiR-15a and MiR-16 Control Bmi-1 Expression in Ovarian CancerCancer Research, 2009
- Autophagy induced by valproic acid is associated with oxidative stress in glioma cell linesNeuro-Oncology, 2009
- Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trialThe Lancet Oncology, 2009
- IDH1andIDH2Mutations in GliomasNew England Journal of Medicine, 2009
- Postradiation Sensitization of the Histone Deacetylase Inhibitor Valproic AcidClinical Cancer Research, 2008
- EXPRESSION OF CONCERN: Inhibitors of histone deacetylase (HDAC) restore the p53 pathway in neuroblastoma cellsBritish Journal of Pharmacology, 2008
- Radiotherapy plus Concomitant and Adjuvant Temozolomide for GlioblastomaNew England Journal of Medicine, 2005
- Chlorimipramine: A novel anticancer agent with a mitochondrial targetBiochemical and Biophysical Research Communications, 2005
- The antidepressants imipramine, clomipramine, and citalopram induce apoptosis in human acute myeloid leukemia HL-60 cells via caspase-3 activationJournal of Biochemical and Molecular Toxicology, 1999